Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline - Sessa, C; Balmaña, J; Bober, S L; Cardoso, M J; Colombo, N; Curigliano, G; Domchek, S M; Evans, D G; Fischerova, D; Harbeck, N; Kuhl, C; Lemley, B; et al. (Annals of oncology, 2023)
Keywords: nádory vaječníků; nádory prsu; Neoplastic Syndromes, Hereditary; Female; chování snižující riziko; časná detekce nádoru; dědičné nádorové syndromy; risk reduction; ženské pohlaví; lidé; Breast Neoplasms; Ovarian Neoplasms; genetická predispozice k nemoci; Genetic Predisposition to Disease; Risk Reduction Behavior; ESMO Clinical Practice Guideline; Early Detection of Cancer; hereditary breast and ovarian cancer syndromes; BRCA; Humans